Wellness
Toxic chemicals in school uniforms face ban

Peers are being urged to ban synthetic fibres and ‘forever chemicals’ in school uniforms due to concerns over long-term health risks from regular exposure.
The call follows two proposed amendments to the children’s wellbeing and schools bill, which is currently at committee stage in the House of Lords.
The bill, which applies mainly to England and Wales, also includes provisions on uniform affordability and limits on branded items.
Amendments 202A and 202B seek to restrict harmful substances such as Pfas chemicals and synthetic fibres, which campaigners warn could affect children’s health throughout their lives.
Green party peer Natalie Bennett, who is backing both amendments, warned about the growing risk from combined chemical exposure.
She said: “What we’re failing to grasp is the cocktail effect, which is the fact that all of us, but particularly our children, are being exposed to microplastics and nanoplastics.
“We’re being exposed to Pfas, we’re being exposed to pesticides. And the level of all of these things is mounting up all of the time.”
Bennett added: “The phrase ‘cocktail effect’ comes from river campaigners who started to focus on the environmental impact of this. But actually [this is] what’s happening to human bodies.”
Pfas – or per- and polyfluoroalkyl substances – are a family of thousands of chemicals used for their water- and stain-resistant properties.
They degrade extremely slowly in the body and environment, and some have been linked to health issues such as high cholesterol, fertility problems, immune system disorders, kidney disease, birth defects and certain cancers.
Researchers have detected Pfas and microplastics in human blood, semen, lungs, breast milk, bone marrow, placenta, testicles and brain tissue, raising concerns about their cumulative effect on health.
Amendment 202A proposes an almost immediate ban on Pfas in school uniforms and would require manufacturers to provide digital product passports listing the chemicals used.
Amendment 202B seeks action within 12 months on uniforms that may “endanger the health or safety of persons [or] cause unreasonable public health or environmental health risk”, with a particular focus on artificial fibres.
In 2021, synthetic fibres made up 64 per cent of global fibre production for the apparel industry.
While exact data for school uniforms is lacking, anecdotal evidence suggests most are made from synthetic materials, with natural alternatives marketed as exceptions.
Concerns about synthetic fibres stem from their environmental persistence and the shedding of microfibres – plastic strands less than 5mm in length – into ecosystems and now human bodies.
Research has shown clothing can shed up to 400 microfibres per gram during just 20 minutes of normal wear.
Unlike plastic pollution from discarded garments, this shedding occurs simply through everyday use.
Bennett said: “It’s obviously breathed in.
“So you know, you run for the bus in your blazer, you’re probably taking in great gulps of plastics, straight into your lungs and potentially into your bloodstream.
“And also of course, you know, you touch it and then you touch your mouth and you can also orally ingest it.”
While the full health impacts of microfibres remain under investigation, early research suggests links to oxidative stress and cardiovascular disease.
Dr David Santillo, senior scientist at Greenpeace Research Laboratories, said: “Most parents are probably not aware that the uniforms their children are required to wear may be treated with a mix of forever chemicals, something that is almost impossible to tell from the label.
“Although some Pfas are already banned in textiles, there are many more still in widespread use.
“Only a ban on the whole group will be effective in reducing children’s exposure to these chemicals while they are at school.”
News
Gut-friendly foods may damage heart, charity warns
News
Diabetes patients face increased risk of undiagnosed heart failure

People with diabetes may have undiagnosed heart failure that could be detected by a simple screening blood test, research suggests.
The TARTAN-HF trial found that one in four patients with diabetes who had at least one other risk factor for heart failure had undiagnosed heart failure detected through screening with a blood test and ultrasound scanning of the heart.
Experts said the findings show the extent of unrecognised heart failure in people with diabetes, and how the condition can be detected using a widely available blood test called NT-proBNP, which measures how much strain the heart is under.
They suggest a heart failure screening programme for diabetics could improve diagnosis rates, lead to earlier treatment and potentially reduce the risk of hospitalisation and death.
The study, involving 700 patients, was led by the University of Glasgow in collaboration with AstraZeneca, Roche Diagnostics, Us2.ai, NHS Greater Glasgow and Clyde and NHS Lanarkshire.
Dr Kieran Docherty, clinical senior lecturer at the University of Glasgow’s School of Cardiovascular and Metabolic Health, said: “Our results from the landmark TARTAN-HF trial identified heart failure in a large proportion of people living with diabetes, emphasising the need for a heart failure screening strategy in this group of patients.
“We know that many of the symptoms and signs of heart failure are non-specific, and may go unrecognised as potentially being due to heart failure for a long time.
“The strategy used in our trial is simple and easy to implement in clinical practice, and will aid in the early identification of heart failure in people with diabetes, and facilitate the initiation of medications that we know improve outcomes in patients with heart failure.”
The study, which began more than three years ago, involved more than 700 people with diabetes from the two health board areas who had at least one other risk factor for heart failure.
They were randomly assigned either to receive heart failure screening or to continue with their usual care.
Researchers found screening uncovered a large number of previously unrecognised cases of heart failure. Around one in four, or 24.9 per cent, of those screened were found to have the condition within six months, compared with 1 per cent in the group continuing their usual care.
The study, involving patients with type 1 and type 2 diabetes, found almost all of the participants found to have heart failure had preserved ejection fraction, which can be difficult to detect without dedicated testing.
The findings of the TARTAN-HF trial were presented at the American College of Cardiology conference taking place from 28 to 30 March in New Orleans in the US.
Dr Edward Piper, medical director at AstraZeneca UK, said: “Delayed diagnosis and treatment of heart failure in people with type 2 diabetes contributes to poor long-term outcomes. TARTAN-HF demonstrates that targeted, risk-based screening can identify previously undiagnosed heart failure in approximately one in four high-risk patients with diabetes, enabling earlier intervention with guideline-directed therapy.”
Dr Christian Simon, head of global medical affairs at Roche Diagnostics, said: “We are proud to have supported the landmark TARTAN-HF trial. These findings demonstrate the transformative power of early, accessible diagnostics like the NT-proBNP blood test.
“By identifying unrecognised heart failure in people with diabetes, we enable clinicians to initiate appropriate treatments sooner, ultimately improving patient outcomes and lives.”
News
UK government announces £6.3m fund to boost men’s health

The UK has launched a £6.3m men’s health fund to back local projects aimed at helping men and boys live longer, healthier lives.
The Men’s Health Community Fund is a partnership between the Department of Health and Social Care, Movember and People’s Health Trust.
The government is contributing £3m, while the two charities are more than doubling that to take the total to £6.3m.
Grants will support community projects reaching underserved men and boys aged 16 and over, particularly in the most disadvantaged areas and at key points in their lives such as becoming a father, losing a job or retiring.
Projects could include support for new fathers, activities for men facing loneliness and social isolation, services to help young men engage with the health system, and support for men in work, out of work and moving into retirement.
The programme will bring together voluntary, community and social enterprise organisations to test new ways of reaching men who are least likely to use traditional health services.
An evaluation funded through the National Institute for Health and Care Research will assess what works and help inform future policy and delivery.
Health and social care secretary Wes Streeting said: “Too many men across the country are living shorter, less healthy lives, particularly those in our most disadvantaged communities.
“This new partnership will help men get the support they need in the places they feel most comfortable, their communities, among people they trust.
“By working with expert charities and local organisations, we can reach the men who are too often missed by traditional services and help them take better care of their mental and physical health.”
“It is a key step in delivering our first ever Men’s Health Strategy and driving forward our ambition to halve the gap in healthy life expectancy between the richest and poorest areas.”
The Men’s Health Strategy sets out plans to tackle the physical and mental health challenges men and boys face.
Men can be less likely to seek help and more likely to suffer in silence, while higher rates of smoking, drinking, gambling and drug use are damaging men’s health and affecting families, workplaces and communities.
The government is also investing £3.6m over the next three years in suicide prevention projects for middle-aged men in local communities across areas of England where men are most at risk, many of which are also among the most deprived. Suicide is one of the biggest killers of men under 50, and three-quarters of all suicides are men.
The projects will aim to break down barriers middle-aged men face in seeking support, including stigma around asking for help and a lack of awareness of what is available and how to access it.
They will be co-designed with experts and men with lived experience of mental health crises and suicidal thoughts.








